Stevanato Group S.p.A. (STVN) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Buy
Based on 8 analysts41.1% Below Target
STVN trades 41.1% below Wall Street's consensus target of $24.75.
Current Price$17.54
Average Target$24.75
Target
Current
Low$17.50
Median$24.75
High$32.00
Analyst Target Range
Forward P/E28.8x
(Growth Premium)
PEG Ratio2.43
(Pricey)
Implied Growth+18.1%
(Moderate)
Analyst Spread58.6%
(Moderate)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes STVN achieves its forward estimates and maintains a stable P/E multiple of 28.8x. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
STVN Price Target Analysis
Updated June 21, 2026As of June 21, 2026, Stevanato Group S.p.A. (STVN) has a Wall Street consensus price target of $24.75, based on estimates from 8 covering analysts. With the stock currently trading at $17.54, this represents a potential upside of +41.1%. The company has a market capitalization of $4.79B.
Analyst price targets range from a low of $17.50 to a high of $32.00, representing a 59% spread in expectations. The median target of $24.75 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, STVN trades at a trailing P/E of 31.2x and forward P/E of 28.8x. The forward PEG ratio of 2.43 reflects a premium valuation. Analysts expect EPS to grow +18.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $18.89, with bear and bull scenarios of $11.90 and $24.89 respectively. Model confidence stands at 50/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+14.5%
Industry Consensus
Avg Forward P/E
22.8x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 APOGApogee Enterprises, Inc. | $888M | $41.27 | $46.00 | +11.5% | Hold | 12.0x | 6 |
 BCPCBalchem Corporation | $5.3B | $165.92 | $175.50 | +5.8% | Buy | 31.7x | 10 |
 BDXBecton, Dickinson and Company | $52.2B | $143.98 | $174.81 | +21.4% | Hold | 11.4x | 34 |
 WSTWest Pharmaceutical Services, Inc. | $23.6B | $328.03 | $330.83 | +0.9% | Buy | 38.1x | 15 |
 GTLSChart Industries, Inc. | $10.0B | $207.99 | $193.81 | -6.8% | Buy | 29.9x | 37 |
 AVTRAvantor, Inc. | $6.5B | $9.58 | $9.17 | -4.3% | Hold | 12.2x | 26 |
 AZTAAzenta, Inc. | $1.1B | $23.31 | $44.50 | +90.9% | Buy | 52.0x | 12 |
 PFEPfizer Inc. | $143.5B | $25.22 | $26.75 | +6.1% | Hold | 8.5x | 39 |
 LLYEli Lilly and Company | $1.0T | $1098.13 | $1271.24 | +15.8% | Buy | 30.0x | 45 |
 NVONovo Nordisk A/S | $191.9B | $43.19 | $45.00 | +4.2% | Buy | 2.0x | 39 |
STVN — Frequently Asked Questions
Quick answers to the most common questions about buying STVN stock.
What is the STVN stock price target for 2026?
The consensus Wall Street price target for STVN is $24.75, representing 41.1% upside from the current price of $17.54. With 8 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is STVN a buy, sell, or hold?
STVN has a consensus rating of "Buy" based on 8 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $24.75 implies 41.1% upside from current levels.
Is STVN stock overvalued or undervalued?
STVN trades at a forward P/E of 28.773x, representing a moderate valuation. With analysts targeting $24.75 (41.1% implied move), the stock appears reasonably valued with upside.
How high can STVN stock go?
The most bullish Wall Street analyst has a price target of $32 for STVN, while the most conservative target is $17.5. The consensus of $24.75 represents the median expectation. Our quantitative valuation model projects a bull case target of $25 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover STVN stock?
STVN is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 3 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the STVN stock forecast?
The 12-month STVN stock forecast based on 8 Wall Street analysts shows a consensus price target of $24.75, with estimates ranging from $17.5 (bear case) to $32 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $19, with bear/bull scenarios of $12/$25.
What is STVN's fair value based on fundamentals?
Our quantitative valuation model calculates STVN's fair value at $19 (base case), with a bear case of $12 and bull case of $25. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 50/100.
What is STVN's forward P/E ratio?
STVN trades at a forward P/E ratio of 28.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 31.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy STVN stock?
Wall Street analysts are very optimistic on STVN, with a "Buy" consensus rating and $24.75 price target (41.1% upside). 5 of 8 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do STVN price targets vary so much?
STVN analyst price targets range from $17.5 to $32, a 59% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $24.75 consensus represents the middle ground. Our model's $12-$25 range provides an independent fundamental perspective.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare